Anaplastic large cell lymphoma pediatric · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
COG ANHL12P1 protocol N/A - intrathecal component | — | R 96 988 | 21d | — | — | ~6 | ~R 547 538 indirect | — |
EICNHL ALCL99 protocol N/A - intrathecal component | — | R 11 744 | 21d | — | — | ~6 | ~R 36 075 indirect | — |
APO Variant #01 | — | R 3 290 | 42d | — | — | ~1 | ~R 3 290 indirect | — |
3 of 3 regimens shown